Company Description
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.
The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants.
In addition, it distributes human cell, tissue, and cellular and tissue-based products.
Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Country | United States |
IPO Date | Aug 3, 2012 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 5,000 |
CEO | Daniel T. Scavilla |
Contact Details
Address: 2560 General Armistead Avenue Audubon, Pennsylvania United States | |
Website | https://www.globusmedical.com |
Stock Details
Ticker Symbol | GMED |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001237831 |
CUSIP Number | 379577208 |
ISIN Number | US3795772082 |
Employer ID | 04-3744954 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Daniel T. Scavilla | President, Chief Executive Officer & Director |
Keith W. Pfeil | Chief Financial Officer & Chief Operating Officer |
Brian J. Kearns | Senior Vice President of Business Development & Investor Relations |
David C. Paul | Co-Founder & Executive Chairman |
Kelly G. Huller Esq. | Senior Vice President, General Counsel & Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 04, 2024 | 4 | Filing |
Nov 25, 2024 | 4 | Filing |
Nov 25, 2024 | 4 | Filing |
Nov 25, 2024 | 4 | Filing |
Nov 20, 2024 | 4 | Filing |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 08, 2024 | 4 | Filing |
Nov 08, 2024 | 4 | Filing |
Nov 05, 2024 | 10-Q | Quarterly Report |
Nov 05, 2024 | 8-K | Current Report |